Skip to main content

300K Solutions

Logo en svg 300k
Menu

300K Solutions featured in Farmabiotec Magazine for its innovation in biomarker stabilization

Farmabiotec Magazine, in its issue no. 18 (2025), features 300K Solutions in its biotechnology innovation section.

Loading Viewer...

In the interview, Fernando Martín de Lara, CEO of the company, discusses the latest developments in biomarker stabilization and how this technology improves sample quality and traceability from the pre-analytical phase.

The publication highlights 300K’s approach as a sustainable and efficient alternative to traditional preservation methods, supporting the advancement of personalized medicine, biomedical research, and clinical trials.

This feature in Farmabiotec reinforces 300K’s commitment to knowledge transfer and technological innovation in the field of biomedicine.

Read the full interview at: Farmabiotec Issue 18 (2025)

Stay updated on our activities!

Linkedin Twitter

La revista Farmabiotec, en su número 18 (2025), dedica un espacio a 300K Solutions dentro de su sección de innovación biotecnológica.

En la entrevista, Fernando Martín de Lara, CEO de la compañía, aborda los avances en estabilización de biomarcadores y cómo esta tecnología está ayudando a mejorar la calidad y la trazabilidad de las muestras desde la fase preanalítica.

La publicación destaca cómo la propuesta de 300K ofrece una alternativa sostenible y eficiente a los métodos tradicionales de conservación, contribuyendo al desarrollo de la medicina personalizada, la investigación biomédica y los ensayos clínicos.

Esta aparición en Farmabiotec refuerza el compromiso de 300K con la transferencia de conocimiento y la innovación tecnológica aplicada a la biomedicina.

Puedes leer la entrevista completa en la web de la revista: Farmabiotec Nº18 (2025)

¡Mantente al día de nuestras actividades!​

Linkedin Twitter

One Technology. Infinite Possibilities.

DNA

RNA

PLASMA/ SERUM

BLOOD CELL FRACTION

WHOLE BLOOD

TISSUES

We are opening a collaborative space to explore and discuss potential applications of 300K technology.

Our goal is to foster knowledge exchange between researchers, clinicians and innovators interested in real-world use cases.

CONNECT, EXPLORE, AND EXCHANGE IDEAS ON 300K APPLICATIONS

Join Our New Forum

Share:

More Posts

Centre international de Recherche sur le Cancer

300K Solutions initiates validation study with International Agency for Research on Cancer (IARC), the specialized cancer research agency of the World Health Organization (WHO) in Lyon, Francia

300K Solutions has initiated a technical validation study with the International Agency for Research on Cancer (IARC), the specialized cancer research agency of the World Health Organization. The study will compare the quality and functionality of DNA samples stored at room temperature with samples preserved at −80 °C.

IMIB Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca

IMIB renews it’s trust with 300K Solutions

Following the successful validation of 300K Solutions’ DNA stabilization technology, the IMIB Biobank has launched a new biological sample preservation project for one of its clients. The initiative reinforces both organizations’ collaboration and supports more efficient, flexible, and sustainable biobanking practices.

Fundación Instituto Valenciano de Oncología (FIVO)

FIVO continues to trust 300K Solutions

FIVO continues its long-standing collaboration with 300K Solutions through the acquisition of DNA and plasma stabilization kits. This partnership supports innovative, sustainable sample preservation and advances high-quality cancer research and precision medicine.

Contact Us